VoxNeuro Raises $3.4M in Funding
Summary
VoxNeuro Inc., a Boston, MA-based company that develops EEG-based brain performance software, closed its second financing round with nearly USD $3.4m raised. The company intends to use the funds to execute commercial expansion plans to scale clinical installations across the US. Led by Jason Flowerday, Chief Executive Officer, VoxNeuro develops EEG-based brain performance software to objectively assess cognitive function. Its first in-clinic product, VoxNeuro CORE, leverages event-related potentials (ERPs) to provide clinicians with easy-to-interpret reports on their patients’ cognitive function. The new machine learning algorithm boasts advanced features that promote increased precision, specificity and a more holistic view of patients’ cognitive health.